The combination of ruxolitinib and MK2206 inhibits cell growth via activating P53 and PTEN expression and decreasing PI3K expression in triple negative breast cancer cell line

dc.authorid0000-0002-3368-9700
dc.contributor.authorCelik, Esin Guvenir
dc.contributor.authorEroglu, Onur
dc.date.accessioned2025-05-20T19:00:53Z
dc.date.issued2022
dc.departmentBilecik Şeyh Edebali Üniversitesi
dc.description54th Conference of the European-Society-of-Human-Genetics (ESHG) -- AUG 28-31, 2021 -- ELECTR NETWORK
dc.description.abstract[No abstract available]
dc.description.sponsorshipEuropean Soc Human Genet
dc.description.sponsorshipBilecik Seyh Edebali University Research Projects [2018-02, BSEU.01-01]
dc.description.sponsorshipThis study was financially supported by Bilecik Seyh Edebali University Research Projects (Project No. 2018-02.BSEU.01-01).
dc.identifier.endpage388
dc.identifier.issn1018-4813
dc.identifier.issn1476-5438
dc.identifier.issueSUPPL 1
dc.identifier.scopusqualityQ1
dc.identifier.startpage388
dc.identifier.urihttps://hdl.handle.net/11552/8843
dc.identifier.volume30
dc.identifier.wosWOS:000779367701480
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWoS
dc.indekslendigikaynakWoS - Science Citation Index Expanded
dc.indekslendigikaynakWoS - Conference Proceedings Citation Index-Science
dc.language.isoen
dc.publisherSpringernature
dc.relation.ispartofEuropean Journal of Human Genetics
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250518
dc.titleThe combination of ruxolitinib and MK2206 inhibits cell growth via activating P53 and PTEN expression and decreasing PI3K expression in triple negative breast cancer cell line
dc.typeConference Object

Dosyalar